FR2944805B1 - Signature moleculaire pronostique des sarcomes et utilisations - Google Patents

Signature moleculaire pronostique des sarcomes et utilisations Download PDF

Info

Publication number
FR2944805B1
FR2944805B1 FR0901936A FR0901936A FR2944805B1 FR 2944805 B1 FR2944805 B1 FR 2944805B1 FR 0901936 A FR0901936 A FR 0901936A FR 0901936 A FR0901936 A FR 0901936A FR 2944805 B1 FR2944805 B1 FR 2944805B1
Authority
FR
France
Prior art keywords
sarcomes
molecular signature
prognostic molecular
prognostic
signature
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0901936A
Other languages
English (en)
French (fr)
Other versions
FR2944805A1 (fr
Inventor
Frederic Chibon
Jean Michel Coindre
Alain Aurias
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Bergognie Fr
Universite Victor Segalen Bordeaux 2
Original Assignee
INST BERGOGNIE
Universite Victor Segalen Bordeaux 2
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by INST BERGOGNIE, Universite Victor Segalen Bordeaux 2 filed Critical INST BERGOGNIE
Priority to FR0901936A priority Critical patent/FR2944805B1/fr
Priority to PCT/FR2010/000323 priority patent/WO2010122243A1/fr
Priority to JP2012506544A priority patent/JP5865241B2/ja
Priority to EP10718241A priority patent/EP2473622A1/fr
Priority to US13/265,764 priority patent/US9708666B2/en
Priority to CA2759417A priority patent/CA2759417C/fr
Publication of FR2944805A1 publication Critical patent/FR2944805A1/fr
Application granted granted Critical
Publication of FR2944805B1 publication Critical patent/FR2944805B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR0901936A 2009-04-22 2009-04-22 Signature moleculaire pronostique des sarcomes et utilisations Expired - Fee Related FR2944805B1 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FR0901936A FR2944805B1 (fr) 2009-04-22 2009-04-22 Signature moleculaire pronostique des sarcomes et utilisations
PCT/FR2010/000323 WO2010122243A1 (fr) 2009-04-22 2010-04-21 Signature moléculaire pronostique des sarcomes et utilisations
JP2012506544A JP5865241B2 (ja) 2009-04-22 2010-04-21 肉腫の予後分子署名およびその使用
EP10718241A EP2473622A1 (fr) 2009-04-22 2010-04-21 Signature moléculaire pronostique des sarcomes et utilisations
US13/265,764 US9708666B2 (en) 2009-04-22 2010-04-21 Prognostic molecular signature of sarcomas, and uses thereof
CA2759417A CA2759417C (fr) 2009-04-22 2010-04-21 Signature moleculaire pronostique des sarcomes et utilisations

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0901936 2009-04-22
FR0901936A FR2944805B1 (fr) 2009-04-22 2009-04-22 Signature moleculaire pronostique des sarcomes et utilisations

Publications (2)

Publication Number Publication Date
FR2944805A1 FR2944805A1 (fr) 2010-10-29
FR2944805B1 true FR2944805B1 (fr) 2018-04-06

Family

ID=42077215

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0901936A Expired - Fee Related FR2944805B1 (fr) 2009-04-22 2009-04-22 Signature moleculaire pronostique des sarcomes et utilisations

Country Status (6)

Country Link
US (1) US9708666B2 (enrdf_load_stackoverflow)
EP (1) EP2473622A1 (enrdf_load_stackoverflow)
JP (1) JP5865241B2 (enrdf_load_stackoverflow)
CA (1) CA2759417C (enrdf_load_stackoverflow)
FR (1) FR2944805B1 (enrdf_load_stackoverflow)
WO (1) WO2010122243A1 (enrdf_load_stackoverflow)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3064594A1 (en) 2015-03-06 2016-09-07 Université de Bordeaux Signature of clinical outcome in uterine smooth muscle tumor analysis, and method of diagnosis thereof
WO2017210662A1 (en) * 2016-06-03 2017-12-07 Castle Biosciences, Inc. Methods for predicting risk of recurrence and/or metastasis in soft tissue sarcoma
RU2625035C1 (ru) * 2016-09-06 2017-07-11 Федеральное государственное бюджетное учреждение "Ростовский научно-исследовательский онкологический институт" Министерства здравоохранения Российской Федерации Способ прогнозирования рецидивирования сарком мягких тканей
EP3530758A1 (en) 2018-02-23 2019-08-28 Université de Bordeaux Method for determining the in vitro presence of a target molecule in a biological sample, and its use for the in vitro analysis of cancers, in particular soft-tissue sarcomas and gastrointestinal stromal tumors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004030615A2 (en) * 2002-10-02 2004-04-15 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
WO2004048938A2 (en) * 2002-11-26 2004-06-10 Protein Design Labs, Inc. Methods of detecting soft tissue sarcoma, compositions and methods of screening for soft tissue sarcoma modulators
JP2008500057A (ja) * 2004-05-27 2008-01-10 バーテックス　ファーマシューティカルズ　インコーポレイテッド Ｉｍｐｄｈ経路の阻害をモニタリングするためのバイオマーカー
EP1806413A1 (en) * 2006-01-06 2007-07-11 Oligene GmbH An in-vitro-method and means for determination of different tumor types and predicting success of surgical procedures in ovarian cancer
US8130007B2 (en) * 2006-10-16 2012-03-06 Formfactor, Inc. Probe card assembly with carbon nanotube probes having a spring mechanism therein

Also Published As

Publication number Publication date
US20130065772A1 (en) 2013-03-14
FR2944805A1 (fr) 2010-10-29
US9708666B2 (en) 2017-07-18
CA2759417C (fr) 2018-05-08
EP2473622A1 (fr) 2012-07-11
JP5865241B2 (ja) 2016-02-17
WO2010122243A1 (fr) 2010-10-28
CA2759417A1 (fr) 2010-10-28
JP2012524537A (ja) 2012-10-18

Similar Documents

Publication Publication Date Title
EP2640854A4 (en) NC RNA AND USE THEREOF
EP2344962A4 (en) DETECTION OF CONFIDENTIAL INFORMATION
EP2365962A4 (en) AMINO ALCOHOL LIPIDOIDS AND APPLICATIONS THEREOF
EP2263087A4 (en) MARKED REACTANDS AND ITS USE
EP2493418A4 (en) BIODEGRADABLE WRAPPING AND ITS USE
EP2638052A4 (en) SELECTIVE GLYCOSIDASE HEMMER AND ITS USE
EP2605789A4 (en) MODIFIED RELAXINPOLYPEPTIDES AND ITS USES
EP2351575A4 (en) NEW USE OF GRS PROTEINS OR FRAGMENTS THEREOF
EP2504439A4 (en) OPTIMIZED ENDONUCLEASE AND ITS USE
EP2422194A4 (en) Vesicular system and uses thereof
EP2473634A4 (en) TD PROBE AND ITS USES
BRPI1007533A2 (pt) prevencao de cartao falso-positiva
BRPI1007612A2 (pt) instalação de centro de dados e centro de dados
EP2426110A4 (en) PYRAZOLYL-ACRYLNITRILE COMPOUNDS AND THEIR USES
BR112012002877A2 (pt) dilatador e conjunto.
EP2646446A4 (en) Bromodomain inhibitors and uses thereof
EP2640792A4 (en) Adhesive compositions and use thereof
EP2655388A4 (en) SELECTIVE GLYCOSIDASE HEMMER AND ITS USE
EP2445894A4 (en) KETAL COMPOUNDS AND ITS USES
EP2576776A4 (en) MODIFIED BETA-LACTAMASES AND METHODS AND RELATED USES
EP2483292A4 (en) Variant LOV-D-POLYPEPTIDE AND ITS USES
EP2593463A4 (en) FORMULATIONS OF RIFAXIMINE AND APPLICATIONS THEREOF
EP2637503A4 (en) SELECTIVE GLYCOSIDASE HEMMER AND ITS USE
EP2582836A4 (en) PRPK-TPRKB MODULATORS AND ITS APPLICATIONS
EP2608785A4 (en) LIPOMA CYCLES AND ITS USES

Legal Events

Date Code Title Description
CD Change of name or company name

Owner name: UNIVERSITE BORDEAUX SEGALEN, FR

Effective date: 20111108

Owner name: INSTITUT BERGOGNIE, FR

Effective date: 20111108

PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 10

PLFP Fee payment

Year of fee payment: 11

PLFP Fee payment

Year of fee payment: 12

ST Notification of lapse

Effective date: 20211205